Preventive effects of exogenous phospholipases on inhibition by ferrous ions of [3H]MK-801 binding in rat brain synaptic membranes

Neurochemistry International

Volumn 34, Issue 3, 1999, Pages 193-201

  Ogita, Kiyokazu ^a   Shuto, Makoto ^a   Manabe, Takayuki ^a   Kuramoto, Nobuyuki ^a   Yoneda, Yukio ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DIZOCILPINE; ION CHANNEL; MEMBRANE PHOSPHOLIPID; PHOSPHOLIPASE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; CHANNEL GATING; CONTROLLED STUDY; FATTY ACID METABOLISM; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC MEMBRANE;

ANIMALS; BRAIN; DIZOCILPINE MALEATE; FATTY ACIDS; FERROUS COMPOUNDS; FREE RADICAL SCAVENGERS; IRON CHELATING AGENTS; MALE; PHOSPHOLIPASES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; SYNAPTIC MEMBRANES; TRITIUM;

ANIMALIA;

EID: 0032947172     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00087-4     Document Type: Article

References (42)

1. 2+-induced oxidative stress. J. Neurochem. 67:1996;1153-1163.
2. Andorn A.C., Britton R.S., Bacon B.R. Ascorbate-stimulated lipid peroxidation in human brain is dependent on iron but not on hydroxyl radical. J. Neurochem. 67:1996;717-722.
3. Benkovic S.A., Connor J.R. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J. Comp. Neurol. 45:1993;97-113.
4. Bradbury M.W.B. Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 69:1997;443-454.
5. Choi D.W. Glutamate neurotoxicity and disease of the nervous system. Neuron. 1:1988;623-634.
6. Collingridge G.L., Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. Sci. 11:1990;290-296.
7. Cotman C.W., Monaghan D.T., Ganong A.H. Excitatory amino acid transmission: NMDA receptors and Hebb-type synaptic plasticity. Ann. Rev. Neurosci. 11:1988;61-80.
8. Ehlers M.D., Zhang S., Bernhardt J.P., Huganir R.L. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell. 84:1996;745-755.
9. 3H]MK-801 binding in brain synaptic membranes. J. Neurochem. 59:1992;473-481.
10. Floyd R.A., Carney J.M. Age influence on oxidative events during brain ischemia/reperfusion. Arch. Gerontol. Geriatr. 12:1991;155-177.
11. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
12. Hall E.D., Braughler J.M. Free radical in CNS injuries. Waxman S.G. Molecular and Cellular Approaches to the Treatment of Neurological Disease. 1993;81-105 Raven Press, New York.
13. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
14. 3H]MK-801 binding to an ion channel associated with the N-methyl-D-aspartate receptor complex in rat brain. Neurochem. Int. 26:1995;59-68.
15. Hill J.M., Switzer R.C. The regional distribution and cellular localisation of iron in the rat brain. Neuroscience. 11:1984;595-603.
16. Hitzemann R.J., Harris R.A. Developmental changes in synaptic membrane fluidity: a comparison of 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-[4-(trimethylamino)-phenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH). Brain Res. 316:1984;113-120.
17. Hollmann M., Heinemann S. Cloned glutamate receptors. Ann. Rev. Neurosci. 23:1994;31-108.
18. Lei S.Z., Pan Z-H., Aggarwal S.K., Cen H-S.V., Hartman J., Sucher N.J., Lipton S.A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron. 8:1992;1087-1099.
19. Linseman K.L., Larson P., Braughler J.M., McCall J.M. Iron-initiated tissue oxidation: lipid peroxidation, vitamin E destruction and protein thiol oxidation. Inhibit by a novel antioxidant, U-78517F. Biochem. Pharmacol. 45:1993;1477-1482.
20. Lipton S.A., Rosenberg P.A. Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330:1994;613-622.
21. Lipton S.A., Choi Y-B., Pan Z-H., Lei S.Z., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
22. Lodge D., Collingridge G. The pharmacology of excitatory amino acids. A TiPS special report. Trends Pharmacol. Sci. special issue:1991;1-89.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540.
25. Nakanishi S., Masu M. Molecular diversity and functions of glutamate receptors. Ann. Rev. Biophys. Biomol. Struct. 23:1994;319-348.
26. Ogita K., Shuto M., Yoneda Y. Nitric oxide-independent inhibition by sodium nitroprusside of the native N-methyl-D-aspartate recognition domain in a manner different from that by potassium ferrocyanide. Neurochem. Int. 33:1998;1-9.
27. 3H]MK-801 binding in brain synaptic membranes. J. Neurochem. 59:1991;1008-1016.
28. 3H]glutamate in rat brain. Life Sci. 39:1986;2411-2418.
29. 2+ elevation. Neurochem. Res. 20:1995;779-784.
30. Rauch S.L., Hitzemann R.J. Developmental changes in synaptic membrane order: a comparison of regions in the rat brain. Brain Res. 391:1986;221-227.
31. Riederer P., Sofic E., Rausch W-D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B.H. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J. Neurochem. 52:1989;515-520.
32. 3H]MK-801 binding by ferrous (II) but not ferric (III) ions in a manner different from that by sodium nitroprusside (II) in rat brain synaptic membranes. J. Neurochem. 69:1997;744-752.
33. Stocks J., Gutteridge J.M.C., Sharp R.J., Dormandy T.L. Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clin. Sci. Mol. Med. 47:1974;215-222.
34. Stocks J., Gutteridge J.M.C., Sharp R.J., Dormandy T.L. The inhibition of lipid autooxidation by human serum and its relationships to serum proteins and alpha-tocopherol. Clin. Sci. Mol. Med. 47:1974;223-233.
35. Sullivan J.M., Traynelis S.F., Chen H-S.V., Escobar W., Heinemann S.F., Lipton S.A. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron. 13:1994;929-936.
36. Suzuki T., Ogita K., Yoneda Y. Potentiation by polyamine of an interaction of noncompetitive antagonists at the N-methyl-D-aspartate receptor ionophore complex with phosphatidylserine. Neurochem. Int. 23:1993;427-440.
37. 2-induced lipid peroxidation in rat amygdala. Neurosci. Lett. 180:1994;33-36.
38. Yehuda S., Youdim M.B.H. Brain iron deficiency. Biochemistry and behavior. Youdim M.B.H. Brain Iron, Neurochemical and Behavioral Aspects. 1988;89-114 Taylor & Francis, London.
39. 3H]glutamate receptor binding assays. Anal. Biochem. 177:1989;250-255.
40. 3H]spermidine in synaptic membranes of rat brain. Brain Res. 563:1991;17-27.
41. Youdim M.B.H., Ben-Shachar D., Riederer P. The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8:1993;1-12.
42. Zhang J-R., Scherch H.M., Hall E.D. Direct measurement of lipid hydroperoxides in iron-dependent spinal neuronal injury. J. Neurochem. 66:1996;355-361.